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In this issue of Europace, Hendriks and colleagues report the findings of a post-hoc analysis of the 
effect of a nurse-led integrated AF care package, supported by a bespoke software system based on 
then current (2010) European Society of Cardiology guidelines, compared to usual care (out-patient 
cardiologist clinic) on all-cause mortality in 712 patients with AF.(1) Integrated care resulted in fewer 
all-cause deaths compared to usual care (13 (3.7%) vs. 29 (8.1%); hazard ratio (HR) 0.44; 95% 
confidence intervals (CI) 0.23-0.85; p=0.014).  Of note, all deaths were adjudicated by an independent 
panel of experts who were blinded to treatment allocation.  
Investigation of the impact of integrated AF care on mortality is important given that 7 out of every 
10 deaths in AF patients are attributable to cardiovascular causes.(2)  Death is finite and although 
other outcomes, such as stroke reduction and quality of life are important, interventions that impact 
on mortality are imperative and identifying what components of these interventions reduce mortality 
(and other outcomes) is vital.  As the authors allude to, guideline-adherent treatment, patient 
education, co-ordinated care and dedicated follow-up, multidisciplinary (MDT) input and 
collaboration, were all elements likely to have contributed to the significant reduction in all-cause 
mortality evident in this post-hoc analysis.(1)  
The interest in integrated care for the management of AF has garnered significant attention over the 
last 6-7 years, propelled by the findings of the original paper by Hendriks et al.(3)  In the original study, 
the primary outcome, a composite of cardiovascular hospitalisation and cardiovascular mortality, was 
significantly lower in the integrated care arm over a mean follow-up of 22-months compared to usual 
care (51 (14.3%) vs. 74 (20.8%), respectively; adjusted HR 0.63; 95% CI 0.44-0.90).(3) Individually, 
cardiovascular hospitalisations (13.5% vs. 19.1%, respectively; HR 0.66; 95% CI 0.46–0.96, p=0.029) 
and cardiovascular mortality (1.1% vs. 3.9%; HR 0.28; 95% CI 0.09–0.85; p=0.025) were significantly 
less in those receiving integrated care compared to usual care.  This was a pivotal paper as integrated 
care as a concept for the management of AF was untested prior to the paper by Hendriks et al.(3) and 
their new data (1) add weight to the call to adopt integrated care as the management approach for 
AF.   
All major clinical guidelines on the management of AF have subsequently advocated a more holistic 
approach to patient care but the guidelines have thus far failed to describe exactly what ‘integrated 
care’ for AF should include.(4-6)  
Why the lack of a standardised definition?  Since 2012 only a few studies have tested ‘integrated AF 
care’ interventions.(7-10)  These studies have varied in their design (2 randomised controlled trials 
(RCT),(8, 9) one cluster RCT,(10) and one ‘before-and-after’ study (7)), setting (primary care (8); 
hospitals(7, 9, 10)), composition, content and delivery (mode, personnel) of the intervention, primary 
outcomes (proportion on appropriate oral anticoagulation (OAC),(10) composite of death or 
unplanned readmission,(9) death, CV hospitalisation and AF-related emergency department (ED) 
visit,(7) unplanned ED visit or cardiovascular hospitalisation(8)), length of follow-up, and perhaps 
fundamentally, all have lacked a theoretical basis for the intervention (i.e., behavioural change 
theory).  The findings have also been inconsistent, with two studies showing benefit of integrated AF 
care,(7, 10) while two have not.(8, 9) 
A nurse-run, physician-supervised AF clinic incorporating group education on AF symptoms, 
investigations and treatment demonstrated a significant reduction in the composite endpoint of 
death, CV hospitalisation and AF-related ED visit (17.3% vs. 26.2%; odds ratio (OR) 0.71; 95% CI 0.59-
0.9; p=0.049) in this ‘before-and-after’ study.(7)  An international, multi-centre study (IMPACT-AF) 
examined the change in the proportion of patients on OAC at 1-year following a comprehensive 
package, including patient and healthcare professional education, with regular monitoring and 
feedback on OAC rates to HCPs.(10) Unsurprisingly, there was a significant increase in OAC 
prescription from baseline to 1-year among those receiving the intervention compared to usual care 
(68-80% vs. 64-67%, respectively; OR 3.28; 95% CI 1.67-6.44 between groups), most likely driven by 
feedback to physicians on OAC rates.(10)  The SAFETY study(9) found no difference in the co-primary 
endpoint of death or unplanned readmission between patients receiving nurse-led care (home visit, 
prolonged follow-up, with MDT support as required) vs. usual care (76% vs. 82%, respectively; HR 0.97; 
95% CI 0.76-1.23; p=0.85).  Most recently, a primary care based intervention, comprising a clinical 
decision support system (guideline-based physician monitoring with optional patient self-
monitoring),(8) did not demonstrate benefit over usual care in reducing unplanned ED visits or CV 
hospitalisation (HR 1.02, 95% CI 0.73-1.41; p=0.93) or major bleeding (HR 0.91, 95% CI 0.32-2.60; 
p=0.87) (Data unpublished, presented at American Heart Association 2018).  
One approach is to streamline the decision-making management approaches to allow them to  be 
uniformly applicable across the whole AF patient pathway, starting with primary care and linking with 
secondary care (including cardiologist and non-cardiologists), and understandable for the AF patients, 
to enable them to engage and manage their care.  Importantly, the approach should be simple, 
practical and easily operationalised. 
The ABC (Atrial Fibrillation Better Care) pathway(11) for the management of AF focuses on important 
outcomes for patients (and physicians), namely reduction in stroke/thromboembolism with 
appropriate anticoagulation, symptom control or elimination, and management of cardiovascular 
comorbidities, to reduce hospitalisation and other adverse outcomes, and to improve quality of life.  
Independent studies have demonstrated that compliance with ABC pathway translates into 
improvement in hard end-points such as death, stroke, and CV events.(12-14)   One prospective clinical 
trial is currently in progress.(15) 
However, a truly integrated AF management, in addition to comprehensive assessment and 
systematic implementation of guideline-adherent therapy, would require other essential 
components, including appropriate interdisciplinary/MDT expert input, co-ordinated care, continual 
appraisal of the care pathway, supported by electronic platforms to guide decision-making and 
capture data for service evaluation,(16) and fundamentally, patient education and empowerment, 
and family/carer involvement. The ABC pathway is adaptable to help operationalise this, spanning 
multidisciplinary healthcare professionals, healthcare providers, patients and families/carers.   
Clinical decision support tools for healthcare professionals and patients have been developed and 
technological innovation has led to a huge number of apps and other e-health and m-health resources, 
most of which have not been formally tested in prospective trials.  Essential components of integrated 
care for AF need to be clearly defined and supported by evidence.  In order to provide integrated care 
for patients we must make a deliberate effort to change organisations, practice and behaviour to 
systematically implement and achieve the full benefit of clinical interventions and make these changes 
sustainable within different healthcare systems.  Simply providing educational initiatives to a selected 
group of healthcare professionals, without consideration of bespoke needs, behavioural change 
approaches or patient engagement is probably inadequate.  It is not only healthcare providers’ 
practice and behaviour that needs to change, but also that of patients (and perhaps their 
families/carers).    
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